Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML

Hemasphere. 2023 Nov 21;7(12):e981. doi: 10.1097/HS9.0000000000000981. eCollection 2023 Dec.

Authors

Jesse M Tettero^{1

2}, Yara Buisman^{1

2}, Lok Lam Ngai^{1

2}, Costa Bachas^{1

2}, Bjorn T Gjertsen³, Angèle Kelder^{1

2}, Arjan A van de Loosdrecht^{1

2}, Markus G Manz^{4

5}, Thomas Pabst^{5

6}, Willemijn Scholten^{1

2}, Gert J Ossenkoppele^{1

2}, Jacqueline Cloos^{1

2}, David C de Leeuw^{1

2}

Affiliations

¹ Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.
² Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
³ Haukeland University Hospital, Bergen, Norway.
⁴ Department of Medical Oncology and Hematology, University Hospital, Zurich, Switzerland.
⁵ Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
⁶ Department of Medical Oncology, Inselspital, University Hospital, Bern, Switzerland.

No abstract available